Cilostazol prevents retinal ischemic damage partly via inhibition of tumor necrosis factor-α-induced nuclear factor-kappa B/activator protein-1 signaling pathway

Cilostazol is a specific inhibitor of phosphodiesterase III and is widely used to treat ischemic symptoms of peripheral vascular disease. We evaluated the protective effects of cilostazol in a murine model of ocular ischemic syndrome in which retinal ischemia was induced by 5-h unilateral ligation o...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Ishizuka, Fumiya, Shimazawa, Masamitsu, Egashira, Yusuke, Ogishima, Hiromi, Nakamura, Shinsuke, Tsuruma, Kazuhiro, Hara, Hideaki
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BlackWell Publishing Ltd 2013
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4184571/
https://ncbi.nlm.nih.gov/pubmed/25505560
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.6
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia